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Psoriasis is a complex inflammatory skin disease in which 
local vascular changes, T-cell activation, abnormal keratino-
cyte proliferation and differentiation, and neutrophil activa-
tion all contribute to the ongoing disease process. Because of 
recent interest in T-cell activation as a trigger for psoriatic 
lesions, we hypothesized that psoriasis may be triggered by 
superantigens, e.g., toxins of microbial origin that stimulate 
T cells expressing particular T-cell receptor (TCR) fJ chain 
variable (V fJ) gene segments. Lesional skin biopsies and pe-
ripheral blood from two patients with acute exacerbations of 
their psoriasis that appeared to be triggered by infection were 
analyzed for TCR VfJ gene expression using monoclonal 
Previous investigations into the pathogenesis of psoriasis have identified a number of important factors: keratino-cyte (HK) proliferation, vascular alterations, dermal in-fluences on HK growth, lymphocyte activation, neutro-phil attraction, and activation of dermal macrophages 
(Me). It remains controversial whether a primary epidermal defect 
causes elaboration of cytokines that results in increased vascular 
activation and the infiltration of activated T cells, or whether epi-
dermal hyperproliferation occurs secondary to inductive effects me-
diated by cytokines derived from infiltrating cells. Careful histo-
logic examination of early lesions, however, has demonstrated that 
activation of T lymphocytes, endothelial cells, and Me precedes 
epidermal proliferation [1]. Furthermore, immunosuppressive 
drugs such as anti-CD3, methotrexate, corticosteroids, UV irradia-
tion, and cyclosporine A are effective in treating psoriasis [2]. 
Numerous other observations support the concept that an ongo-
ing cellular immune response may contribute to the formation and 
persistence of psoriatic plaques. Localized collections ofHLA-DR + 
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Abbreviations: 
APC: antigen-presenting cell 
HK: human keratinocytes 
IL: interleukin 
MHC: major histocompatibility antigen 
M0: monocyte/macrophages 
SE: staphylococcal enterotoxins 
SEB: staphylococcal enterotoxin B 
SPE: streptococcal exotoxins 
TCR: T-cell receptor 
Vp: variable region of the TCR p chain 
antibodies directed against Vp 5.1,5.2,6.7,8.1, and 12. Skin 
biopsies from both patients demonstrated a different pattern 
of Vp expansion that corresponded to the vp pattern ex-
pec~ed to b.e ind~ced by the type of superantigen expressed 
dUring the mfectlOn. In contrast, using immunofluorescence 
a?d flo,:" cytometry, peripheral blood T cells from these pa-
tients did not demonstrate any expansion of the 5 Vp subsets 
stu~ie~. These observations support the hypothesis that local 
activation of cutaneous T cells in psoriasis may be caused by a 
superantigen and provides a new direction for investigating 
the pathogenesis of this complex and fascinating skin dis-
order.l Invest DermatoI100:225-228, 1993 
HK are seen in psoriatic plaques [3]. IFN-y, a potent inducer of 
HLA-DR on HK, is produced exclusively by activated T cells and 
has been found to be increased in the psoriatic epidermis [4]. Other 
cytokines that mediate skin inflammation such as IL-IP, IL-6, IL-8, 
and TGFa have also bee? reported to be increased in psoriatic 
plaques [5,6]. These cytokmes are thought to be produced by acti-
vated HK as well as infiltrating Me and T cells. 
The mechanisms by which HK, T cells, and Me achieve and 
maintain their activated state in psoriatic skin lesions are unknown. 
Although multiple factors may contribute to the exacerbation of 
psoria~is, there. are a n.U1~ber of reports suggesting that bacterial 
mfection can tngger tillS Illness [7 -10]. In this regard, fifty percent 
of I'atie~ts with psoriasis have been reported to carry S. aureus on 
their skm [8]. S. aureus was more numerous on the psoriatic lesions 
as comp~re? to unmvolved skm. Furthermore, in patients with gut-
tat~ pSOriaSIS, It has been repo~ted that acute exacerbation of psoria-
SIS IS I'rece~ed by antecedent mfection with streptococci pyogenes 
an~ nses m ser~m. anti-streptococcal titers [10] . Patients with 
thiS form of psonasls frequently improve with systemic antibiotic 
therapy. 
Recent studies demonstrating that bacterial toxins can act as su-
perantigens [t.l] provide plausible mechanisms by which S. aureHS 
and streptocoCCI could mediate the activation of epidermal HLA-
DR + HK as. well a~ infiltrating T cells and monocytes in at least a 
subset of patients With psoriasis. The term superantigen refers to a 
group of microbial products that, when bound to MHC class II 
molecules, stimulate T cells expressing particular T-cell receptor 
(TCR) Vp ~ene . segments (reviewed in references [12,13]. These 
molecu.les differ m several respects From conventional peptide anti-
gens. First, unlike conventional peptide antigens, the other compo-
nents ~f.the TCR, i.e., DP, JP, Va, and Ja, play little role in the 
recogmtlon of superantigens. In contrast, superantigen- major his-
t?comp~tibility complex (MHC) class II complexes interact exclu-
sively With the Vp element of the TCR at a region on the lateral face 
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Figure 1. Proposed mechanism for local activation of restricted popula-
tion(s) of T lymphocytes in psoriasis. Although superantigens are 
presented by class II MHC molecules, they do not bind wit~ .the conven-
tional peptide binding groove. Indeed, they do not reqUIre mtracellular 
processing by the antigen presenting cell, and appear to interact with 
amino acid residues on the outer surface of the MHC class II molecule. 
of the Vp domain. Second, whereas recognition of peptide antigens 
by the TCR is restricted by the allele of the presentmg MHC mole-
cule, recognition of superantigens is generally not MHC restricted. 
Finally, unlike peptide antigens, superantigens do not require intra-
cellular processing prior to presentation by M~C class.II molecules, 
and they bind to MHC class II molecules at sites dlstmct from the 
peptide antigen-binding cleft. 
Staphylococcal enterotoxins (SEs) and streptococcal exotoxins 
(SPEs) are prototypic superantigens that can engage HLA-DR on 
M0 to induce the release of cytokines and cause the selective stimula-
tion ofT cells expressing specific TCR Vp gene segments [11]. We 
have also recently demonstrated that Candida albicans, another com-
mon skin pathogen, can also induce proliferation of lymphocyte 
populations of restricted Vp spec!ficity in vitr.o and i'~ vivo althou~h 
conclusive proof of defined Candida superantlgen(s) IS not yet avail-
able.· We pose the question whether bacterial or fungal superanti-
gens might be one trigger of lymphocyte proliferation in psoriasis. 
This hypothesis is supported by the clinical observation that acute 
guttate psoriasis is commonly associated with an acute streptococcal 
pharyngitis [10], and the finding that psoriatic plaques commonly 
occur in the inframammary and intergluteal areas where Candida is 
a common pathogen [14]. 
HYPOTHESIS 
We postulate that superantigens derived from microbial agents such 
as streptococci, staphylococci, and candida may act as a trigger(s) for 
the exacerbation of psoriasis in those patients whose disease is asso-
ciated with infection. In this way they can activate large segments of 
the T-cell repertoire, selecting cell populations with particular V p 
specificity. As illustrated in Figs 1 and 2, this selective expansion of 
large T-cell populations locally could lead to the release of cyto-
kines that promote endothelial cell activation, keratinocyte prolifer-
ation, and other characteristics of psoriasis. This superantigen-
driven T -cell activation might be involved in both the induction or 
persistence of psoriatic lesions. 
With respect to the induction of psoriatic lesions, superantigen(s) 
• Walsh P, Abe J, Giomo R, Norris DA, Leung DYM: Selective stimula-
tion of VpS.l + T cells following stimulation with Ca"dida albicans in vivo 
and in vitro (abstr). Clin Res 40:11A. 1992. 
Induction 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Persistence 
\7 
Stratum ~~~~~~~~~ Corneum" 
Eplderm/. 
Dermis 
..-l"'--... Epicutaneous 
'--v" = Superantigen 
-+ _ Circulating 
- Superantigen 
Dermal 
Dendrocytes 
Figure 2. Potential populations of MHC class II positive APC in either 
the induction or persistance of psoriasis. 
from epicutaneous or subcorneal sources, or from a circulating 
source, could bind to a number of MHC class II bearing antigen-
presenting cells (APC) in the dermis or epidermis (Langerhans cell, 
dermal dendrocyte, dermal macrophage). If lymphocytes were 
present in the dermis, either as a result of the infection producing 
the superantigen, as a result of skin trauma, or as a pre-clinical 
psoriatic lesion, they could bind to dermal or epidermal APCs. If the 
appropriate V p-bearing lymphocyte were present, APC/lympho-
cyte interaction could lead to T-cell activation by superantigen. 
T-cell proliferation, cytokine release, and the characteristic psori-
atic phenotype would then ensue (Fig 2). 
On the other hand, in persistence of psoriatic lesions, groups of 
MHC class II positive keratinocytes might also be added to the list of 
potential APC that could facilitate T-cell activation by superanti-
gen. Lymphocytes recruited into an ongoing psoriatic lesion would 
then be subject to activation if a superantigen capable of binding to 
their Vp chain were presented in the dermis or epidermis by appro-
priate MHC class II-bearing APC. 
In either scenario, superantigen activation might be the only stim-
ulus or one of several stimuli for T-cell activation. In this regard, it 
would also require (especially in the induction of lesions) other 
stimuli to initiate lymphocyte migration into the skin. Genetic fac-
tors are also likely to be important. For example, it is now also well 
known that HLA-DR alleles differ in their ability to present staphy-
lococcal toxins to T cells [15] . Thus MHC class 11 haplotype may 
also play an important role in the response of psoriatic patients to 
different staphylococcal toxins. 
ILLUSTRATIVE CASE REPORTS 
We report two patients with clinical exacerbation of psoriasis in 
which the lesions showed expansion ofT-lymphocyte populations 
with limited TCR V P specificity, corresponding to the V p specifici-
ties stimulated by bacterial or fungal pathogens cultured from the 
lesions. 
Case I KMF is a 52-year-old Japanese-American female with 
plaque psoriasis. Past medical history is negative for serious medical 
illnesses and family history is noncontributory. Her psoriasis has 
been treated with topical steroids, psoralen plus ultraviolet A 
(PUV A), Re-PUV A, and methotrexate. She experiences recurrent 
flares of her cutaneous disease that have responded to intensified 
treatment regimens and to systemic antibiotics. During a flare of her 
cutaneous disease, KMF had numerous acutely inflamed psoriatic 
plaques with extensive crusting and scalp involvement and apparent 
impetiginization of many lesions. A standard aerobic culture and a 
4-mm punch biopsy were obtained from an acutely inflamed psori-
atic plaque. The culture was positive for S. aureus, which secreted 
the superantigen, staphylococcal enterotoxin B (SEB). The skin 
biopsy was processed for assessment ofT-cell repertoire in the cellu-
lar infiltrate and found to demonstrate increased expression of 
VpS.l and VP12 (Fig 3, left) . Stimulation of restingTcells with SEB 
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causes selective expansion of VP12 lymphocytes [11]. In contrast, 
when her peripheral blood T cells were analyzed d~nng acut~ exac-
erbation of her skin disease, there was no selective expansIOn of 
VP12 cells as might be seen following systemic SEB stimulation. 
Case II G]H is a 41-year-old Hispanic female with plaque psoria-
sis. Past medical history is significant for asthma smce adolescence. 
Family history is significant for diabetes mell~tus (two brothers). 
Her psoriasis has been treated with topical sterOIds and PUV A pho-
tochemotherapy. Despite relatively good control o~ her cutaneo~s 
disease with regular PUV A treatments, G]H occaSIOnally expen-
ences acute flares of her psoriasis. During one such flare, a standard 
aerobic culture and a 4-mm punch biopsy were obtained from a 
psoriatic plaque in the right inframamma~ area. The p.laque .con-
tained micropustules that were culture positive for CandIda alb,cans. 
The skin biopsy was processed for assessment o~T-celi repertOlr~ m 
the cellular infiltrate and found to demonstrate mcreased expressIOn 
ofVpS.l and Vp8 (Fig 3, right). Her periph~ral blood ~ cells, how-
ever demonstrated no evidence for selective expansIOn of TCR 
Vp's'during the flare of her. skin d.isease. Interesti~gly, increased 
expression ofVpS.l and VP81s seen m skm test reactions to Candida 
antigen.* 
DISCUSSION 
The hallmark of the cellular infiltrate in the psoriatic plaque is a 
mononuclear cell infiltrate that consists predominan~l~ ~f 
CD4+CD3+ T lymphocytes [16). Immunohist~logic analysIs mdl-
cates that these T lymphocytes bear the CD2S (mterleukm 2 [IL-2) 
receptor} and HLA-DR activat~on antigens. More imp~rtantl~, they 
produce interferon-y, a cytokme that has been ImplIcated m the 
pathogenesis of psoriasis. Other cytokmes such as IL-lP, tumor 
necrosis factor-a, IL-6, IL-2, and IL-8 have also been reported to be 
elevated in psoriatic lesions [S,6) . The pr~duction of these cyto-
kines, particularly IL-tp and TNF-a, by activated T cells, .keratmo-
cytes, and M0 are thought to play an importa~t role in the mduc~lOn 
of adhesion molecules on vascular endothelIal cells and keratlllo-
cytes and the subsequent influx of ~n~ammatory .cell~ in~o the skin. 
The etiologic agent that triggers thiS Immune activation IS currently 
unknown. 
The capacity to cause marked activation of T cel!s and M0 is a 
characteristic of bacterial toxins that act as superantlgens. SEs and 
SPEs are potent inducers of IL-l and tumor necrosis factor-a from 
M0 [17). SEs and SPE-mediated stimulation of M0 is a conseque~ce 
of binding and transducing a positive signal through class II major 
histocompatibility molecules. on the M0 cell sur~ace. In the presence 
of APCs, these bacterial toxms are powerful stlmulator~ of T-cell 
proliferation in culture and do so by selectively stimulatlllg T cells 
expressing particular V p gene segments [11) . For exa~pl.e, the n:a-
jority ofT cells stimulated by staphylococcal TSST -1111 VItro sp~clfi­
cally express Vpz. More importantly, it has ?een shown by Chol et ~l 
[18) that peripheral blood T cells from patients who develop to.XIC 
shock syndrome demonstrate a remarkable expansion of circulatmg 
V P2 + T cells. . ' . 
Our two illustrative cases .support the hYfothesls that psoriasIs 
may be associated with selective expansIOn 0 Vp populatIOns char-
acteristic of superantigenic stimulation. In this regard, we found 
that the T cells infiltrating into the psoriatic skin lesion of two 
patients with acute exacerbation of their skin disease was skewed 
with an increased proportion ofT cells bearing specdlc V p segments 
(Fig 3). Interestingly, the skin lesions from these two patients dem-
onstrated the expansion of different TCR Vp gene segments. Be-
cause the expansion of T cells bearing specific TCR Vps probably 
reflects a reaction to a particular toxin or antigen, thes~ data would 
suggest that different antigens are inducing local activation .of T 
cells in these patients and further underscores the heterogenel~ of 
skin lesions found in patients with psoriasis. Because the eXl;lanslOn 
ofT cells bearing specific TCR Vps probably reflects a reaction to a 
• Walsh P, Abe j, Giomo R, Norris DA, Leung DYM: Selective stimula-
tion of Vp5.1 + T cells following stimulation with CalJdida albiwllS in vivo 
and in vitro (abstr). Clin Res 40:1lA, 1992. 
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Figure 3. TCR expression of the peripheral blood and cellular infiltrate in 
skin lesions of 2 psoriasis patients. Patient 1 had a flare of her psoriasis 
concomitant with a SEB-secreting S. aureus infection. Patient 2 had a flare 
of her psoriasis following a C. albiwlJS infection. In these experiments, we 
used monoclonal antibodies directed at Vp 5.1,5.2,6.7,8.1, and 12 to 
stain 4-mrn cryostat sections from snap-skin biopsies of psoriatic skin 
lesions using a labeled avidin-biotin method as previously described [23]. 
Results are expressed as a percent of total CD3 reactive T cells. Peripheral 
blood T cells were analyzed for TCR Vp expression as previously de-
scribed [24,25] using immunofluorescence with biotinylated monoclonal 
antibodies directed at the above five different Vpsegments. The percent-
age of T cell bearing each TCR V P phenotype was expressed as a percent-
age of total T (CD3 +) cells. 
particular antigen or toxin, these data would suggest that different 
antigens are inducing local activation of T cells in these patients. 
Superantigen-driven T-cell activation might contribute to the 
heterogeneity in psoriasis on two different levels. First, reactions to 
different superantigens may produce lesions with different Vp pat-
terns in the same patients, or among different patients. Secondly, 
reactions to particular superantigens may be relatively genetically 
restricted. Although most MHC class II haplotypes are able to 
present superantigens [19)' different alleles vary in the ability to 
present particular superantigens [15). Hence, the development of 
particular types of psoriasis, may be favored by class II haplotypes 
associated with preferential presentation of particular superanti-
gens. For example, the ability to develop generalized guttate psoria-
sis may depend on a preferential superantigen presentation by one or 
more class II haplotypes. Alternatively, superantigenic activation of 
different types of psoriasis may be a uniform characteristic among 
the different types of psoriasis. 
In this regard, it is of considerable interest that cultures from the 
psoriatic skin lesion of patient 1 grew out S. aureus secreting the 
superantigen, staphylococcal enterotoxin B (SEB) , whereas the skin 
lesion from patient 2 grew out Candida Albicans. SEB is known to 
stimulate T cells in vitro to express the VP12 but not VpS.l, 5.2, 6.7, 
or 8.1 gene segments [11). In contrast, C. Albicans stimulates VpS.l 
and VpS.l in delayed hypersensitivity skin reactions but not VpS.2, 
6.7 or 12.* Thus, the TCR Vp skewing observed in the local infil-
trate of these patients showed some correlation with the superanti-
gen being secreted at their skin surface. Our observation that the V p 
skewing did not correspond exactly with what is seen when purified 
superantigen is introduced into the skin or peripheral blood is not 
surprising because T -cell activation in the local psoriatic lesion may 
be influenced by a variety of exogeneous and endogenous antigens. 
In support of a critical role for these T cells in the pathogenesis of 
psoriasis, the peripheral blood of these patients did not show the 
selective expansion of these Vps. Generally all five variable ele-
ments (VP, DP, ]P, Va, ]a) of the TCR contribute to the recogni-
tion of conventional antigens. Thus, the expansion of a particular 
Vp gene segment is not likely to be seen in a response to conven-
• Walsh P, Abe J, Giomo R, Norris DA, Leung DYM: Selective stimula-
tion of Vp5.l + T cells following stimulation with Calldida albiwlls in ViVO 
and in vitro (abstr). Clin Res 40:11A, 1992. 
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tional antigens because the frequency of responding T cells to such 
antigens are generally very low, i.e., less than one in a hundred T 
cells. In this regard, previous studies of hapten-induced contact 
sensitivity reactions have shown that the frequency of antigen-spe-
cific T cells infiltrating into the skin was less than 1 % [20] . Thus, 
our current observation of the selective expansion ofTCR Vp in the 
cellular infiltrate of psoriatic plaques is consistent with our hypoth-
esis that the stimulus for T-cell activation in at least a subset of 
psoriasis is due to a superantigen. 
We propose that superantigen-driven psoriasis is one of many 
potential mechanisms of T-cell activation in psoriasis. The pattern 
of activation would be expected to be different among different 
patients and in multiple lesions from the same patients. On the 
other hand, generalized, systemic superantigenic effects may be 
seen in patients with strep-pharyngitis induced guttate psoriasis [9]. 
It should be noted that a previous study of TCR repertoire in 
psoriatic lesions in chronic non-pustular psoriasis using the same 
panel of monoclonal anti-Vps as our current study did not demon-
strate any specific selection of a single V region [21]. Selective TCR 
V P stimulation by superantigens, however, are most marked follow-
ing activation of resting T cells [11]. Once T cells express HLA-DR, 
superantigens can sustain activation via their interaction with the 
HLA-DR molecule [22] . Biopsies from the current study were ob-
tained from patients with acute exacerbation of their psoriasis. Fur-
ther studies will be needed to determine whether TCR skewing is 
seen exclusively in the acute lesion, particularly the subset of psoria-
sis associated with infection. Studies will also be needed to examine 
T cell repertoire in other skin diseases to determine whether the 
present findings are unique to psoriasis. Nevertheless, we believe 
that the current observations and hypothesis provides a new direc-
tion for investigating the pathogenesis of this fascinating skin dis-
order. 
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